Implementation and Evaluation of an Enhanced PharmaNet-Based Adverse Drug Event Reporting Platform to Improve Patient Safety and Meet Adverse Drug Reaction Reporting Requirements

基于 PharmaNet 的增强型药品不良事件报告平台的实施和评估，以提高患者安全并满足药品不良反应报告要求

• 批准号: 334597
• 负责人: Balka Ellen
• 金额: $ 48.27万
• 依托单位: Simon Fraser University (Burnaby, B.C.)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2015
• 资助国家: 加拿大
• 起止时间: 2015-06-01 至 2019-06-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=334597&lang=en
• 关键词: Adverse Drug Event Monitoring; Bill C-17 Reporting; Computer Supported Cooperative Work; Participatory Design; Patient Safety; Qualitative Evaluation; Seniors; Step-Wise Implementation

Adverse drug events (ADEs), unintended harmful events resulting from medication use, are a leading cause of emergency department (ED) visits and hospital admissions. Research enrolling over 3000 patients in three BC hospitals suggests that ADEs account fo

药物不良事件（ADE）是药物使用引起的非预期有害事件，是急诊（艾德）就诊和住院的主要原因。在不列颠哥伦比亚省三家医院招募了3000多名患者的研究表明，